Skip to main content
Clinical Trials/NCT04978285
NCT04978285
Completed
Not Applicable

Association of Postoperative Anaemia With Patient-centred Outcomes

Bayside Health1 site in 1 country3,000 target enrollmentJuly 16, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anemia After Surgery
Sponsor
Bayside Health
Enrollment
3000
Locations
1
Primary Endpoint
Persistent disability or death by 90 days
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Primary aim - To investigate the relationship between postoperative anaemia and patient-centred outcomes after major abdominal surgery.

Secondary aim - To determine whether a more liberal perioperative IV fluid strategy increases the risk of postoperative anaemia (haemodilution).

Hypothesis: Adults with anaemia in the immediate postoperative period following major abdominal surgery have a poorer quality of recovery and higher risk of complications, leading to poor disability-free survival when compared with patients without postoperative anaemia.

Detailed Description

The consequences of postoperative anemia remain unclear. Postoperative anaemia is more likely if there is pre-existing anemia, but also increased perioperative blood loss, frequent blood sampling, excess IV fluids (leading to hemodilution), sepsis, and inadequate nutritional intake after surgery. A nadir in Hb concentration is most often observed within the first 3-4 days after surgery. Postoperative anemia is believed to have deleterious effects on patient outcomes, including prolonged hospital stay, increased postoperative complications, and perhaps poor survival, but there is very little data to support this belief. A recent consensus statement suggested that all patients recovering from major surgery (defined as blood loss \> 500 ml or lasting \> 2 h) and either had preoperative anemia or moderate-to-severe blood loss during surgery must be screened for anemia after surgery. Furthermore, this consensus group recommended that patients recovering from uncomplicated major surgery should have their Hb concentration measured for at least 3 days after surgery to detect anemia. As outlined above, this is problematic if there is fluid retention. The role of IV iron for the treatment of postoperative anemia is unclear, with the most recent systematic review concluding that neither oral nor IV iron had a significant effect on patient quality of life or functional outcomes following surgery. A diagnosis of iron deficiency is very difficult in the postoperative period because the acute phase inflammatory response results in spuriously elevated ferritin levels, and several studies have demonstrated oral iron therapy is ineffective in this setting. The investigators propose a study to investigate the incidence, extent, and outcomes of patients with anemia after major surgery, including an assessment of the amount of IV fluids administered in the immediate perioperative period.

Registry
clinicaltrials.gov
Start Date
July 16, 2021
End Date
November 30, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Bayside Health
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults (≥18 years) undergoing elective major surgery and providing informed consent
  • All types of open or lap-assisted abdominal or pelvic surgery with an expected duration of at least 2 hours, and an expected hospital stay of at least 3 days
  • At increased risk of postoperative complications, as defined by any of the following criteria:
  • age ≥70 years
  • known or documented history of coronary artery disease
  • known or documented history of heart failure
  • diabetes currently treated with an oral hypoglycemic agent and/or insulin
  • preoperative serum creatinine \>200 micromol/L (\>2.8 mg/dl)
  • morbid obesity (BMI ≥35 kg/m2)
  • preoperative serum albumin \<30 g/L

Exclusion Criteria

  • Urgent or time-critical surgery
  • ASA physical status 5 - such patients are not expected to survive with or without surgery, and their underlying illness is expected to have an overwhelming effect on outcome (irrespective of fluid therapy)
  • Chronic renal failure requiring dialysis
  • Pulmonary or cardiac surgery - different pathophysiology, and thoracic surgery typically have strict fluid restrictions
  • Liver resection - most units have strict fluid/CVP limits in place and won't allow randomisation
  • Minor or intermediate surgery, such as laparoscopic cholecystectomy, transurethral resection of the prostate, inguinal hernia repair, splenectomy, closure of colostomy - each of these are typically "minor" surgery with minimal IV fluid requirements, generally low rates of complications and mostly very good survival.

Outcomes

Primary Outcomes

Persistent disability or death by 90 days

Time Frame: 90 days after surgery

Defined as a World Health Organization Disability Assessment Schedule 2.0 (WHODAS) score of at least 24 points (on the 48-point scale) at both 30 and 90 days postoperatively, reflecting a disability level of at least 25% and being the threshold point between "disabled" and "not disabled" as per WHO guidelines. Disability was assessed by the participant, but if unable then we used the proxy's report.

Secondary Outcomes

  • ICU stay(30 days)
  • Hospital stay(30 days)
  • Pneumonia(30 days)
  • Death: all-cause mortality at 90 days, then up to 12 months after surgery(1 year)
  • Surgical site infection(30 days)
  • Sepsis: using Centers for Disease Control and Prevention (CDC) with National Healthcare Safety Network (NHSN) criteria(30 days)
  • Unplanned admission to ICU within 30 days of surgery(30 days)
  • Quality of recovery(Postoperative Days 3 and 30)
  • A composite (pooled) and individual septic complications: sepsis, surgical site infection, anastomotic leak, and pneumonia(30 days)
  • Anastomotic leak(30 days)
  • Hospital re-admission(At 3, 6 and 12 months.)
  • Acute kidney injury(30 days)

Study Sites (1)

Loading locations...

Similar Trials